{"name":"Polaris Group","slug":"polaris-group","ticker":"","exchange":"","domain":"polaris.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPbXNObjJWbHpJak5oOGRDRmhUN2tIQWZhWlhNeDlWMWdUdWRRbzNSUG5MdVFTaXRGU2tJZTB4V2d3V1FGMUxtcFBCYlVzM1RxUm1Ndkl2azBlYlJvci1xTndQS0lXSTBCSlpKemdBdU11N0d4MU9yN0xHTTdWZHBOVHl6TFVFMlpOcUhhdTlaVGpBUW4wX1phSU1ueGIzazVIQTQwVkVrTTdFNXNhT0VsenRPS0xBSEFzMHZMRnlULUVGZnNPWTFLTFo1RlAtdFJzSy1ISFlqNW9HT0dEY0FHcUJWa0NUeGd6Tmk0dHNIRjdwc1p6WTRmWVFhSUF6dw?oc=5","date":"2026-03-25","type":"pipeline","source":"GlobeNewswire","summary":"Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates - GlobeNewswire","headline":"Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQRThHamRxMVpHNWkwbVJ1ZVNtTjdIQVd5Y21NVGpZdXQ2eUVPMXZ5NnpPb0x2Y09SdFRGbThTZEU4MFdnRXhQVWgzdFhhTUZLd3g4YmdtekdCR3NpY3dfZkhTVUlHenpZWUtRWnFBLS1NZHQwdi1tTURiNU1NUEZxRDRVdllYSkwtdVRXbloxSGEwU0w2endidGFxcTNSaHlkSWZqUw?oc=5","date":"2025-12-05","type":"regulatory","source":"CancerNetwork","summary":"FDA and EMA Clear Phase 3 POLARIS-1 Trial in Newly Diagnosed Ph+ ALL - CancerNetwork","headline":"FDA and EMA Clear Phase 3 POLARIS-1 Trial in Newly Diagnosed Ph+ ALL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOX3BGYlhZd2FINXFXOTJtaWl0ajV6RnpkcDBVYnNYbmM3d2VhTjJLQlljS2hCQzZyaC05YlcxaVViMWJOWHdRTlpuaEY3M2xueGNNSXpnZnU4cEhBUHNJNzJEX3E1ZFc1N3BBd0cyVUxFdDZyOWpiOVJ1QVg1aDJ5cVFFYkJBX1BQOVhV?oc=5","date":"2025-10-24","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Alkermes, Takeda, BPD Healthcare and more - Medical Marketing and Media","headline":"Rx Rundown: Alkermes, Takeda, BPD Healthcare and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQY2lvaTFCU3JiY3pZb2NQVEYtbFNuZXNTcXN5NHFFdWo2bURTVldObjlCMWF0ak0ycjVtb053UEwwdGV4RFJTeEg1Ql9NQ3hPMWl1M1pMYUk4VUJXdmY2M1kySnZOaHNEQngzMkVlLWNMNk84UkQzQ25MeWNkZlotdGF0aWg1T2p4UVRKWjd2LXZVenM3TGVkdEJuc0ttUzZYb3htdTA2dU04d2QtYm5sTDdWZGNqajQ5?oc=5","date":"2025-10-13","type":"pipeline","source":"Eyes On Eyecare","summary":"Horizon performs world's first robotic-assisted cataract surgery - Eyes On Eyecare","headline":"Horizon performs world's first robotic-assisted cataract surgery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNdVAxQy1zQ01VMG1DQm5HMXo2RjV6REVGZ29wMjJ2VHJUSzlUSzdQTHJlcmxXT2lFdDlVV3RRc2pCbXllLU9Ca2ZIYjhsdkhSS3pZWVZWZXFvSm1aUzl4bW9qd20zMkpTampRZjVHV2Z5RElWd3RJTU53YXRCdXVSbGNNVEVTTzMxSDdaZXR2bm5WaUVRT1Y4TWxRRzhNVFRIdllZUXhsWHVpQmJLTGJJalJzNXRyNWNYdVZDSldDWWo3Q2taWFhjMDhWaUI?oc=5","date":"2025-07-22","type":"regulatory","source":"pehub.com","summary":"Temasek’s 65 Equity leverages growing demand for non-control deals; Partners Group, Polaris, RF bet on pet health - pehub.com","headline":"Temasek’s 65 Equity leverages growing demand for non-control deals; Partners Group, Polaris, RF bet on pet health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPV3htUWN3RXFNelFTbzZ3WkNZelR1MWR5SmdnV2ZZQ2x5VTJWOUdGWmg5NFhtUU8zQm02Nm1nRXZaM09jZmVHTTNkN3EyQ19ucEJael92ZnpzMkkxN19jMWUyUl93c0Q4OWNlSnRRbHVEOHBJamdvUGp2dlJqaDhFRXllaw?oc=5","date":"2025-06-30","type":"deal","source":"statnews.com","summary":"AbbVie snaps up CAR-T company in a deal worth $2.1 billion - statnews.com","headline":"AbbVie snaps up CAR-T company in a deal worth $2.1 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOeTFicFoxbHY1OEFFanprWFlzZy10Rk5ta0lpbklkWmRDeFpIWk0tbklEUnlSU1ZfVjN2T0xTQm5iSWhWM3hqTm00dXBUR1IxNzAweE9rSXdjWFRBclZUeERpREgwSmJHRUoxM290bW5acC1UaDFwU0JCaFRRdmxzWlNVUlBHSU5yQVV6cldfQTZJQ0hyLU9TRU1fUWNuX0U5aFV4a2phSUxySDRERS1mWXpITW9QRU1xLWxxanBKbVliZw?oc=5","date":"2025-06-27","type":"pipeline","source":"Bloomberg.com","summary":"Mystery $33 Billion Medicine Fortune Collapses in Days - Bloomberg.com","headline":"Mystery $33 Billion Medicine Fortune Collapses in Days","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AJBVV95cUxOWTFtLWd4RlVWZmNnVTNVYlVlTEJmZkplN3g3bF9QeElkdEk5MkswN2RRRS1OM0Nrc0pnaGVyQ09UWVhkSU84YnJscmVBcUZXMnBBdlNNMVFieWt1d3MwQjlXbGRJZ3NkdzB0S0J4NmRjbkJiTlB3RUpsNXNfR3dEcm1MTWdzQWJKeURjX2R0UGljbWlSOUowZ2xlcHQtaFh1NDg2MjNaaG1FakpELXcteWo1QjBqNjRJQmJTX0xfT3FkSjlQTmNycTkyOGEtMFVpUWFXcjF2REtuckVFRDhCdTN0WjRxaW1tbnhjQjlLbVN6T0lhVWFuTW1DdmZmcjZaS1p2RHd5eDgyVzk0VHZLeFBEODE4bDhzT1BMcWJqUHhsVElMLVJ1c0VoWlI2Sms5TWNjOGZ6M3Q3NmJkbWYtM2FNUHIxemdHVTh0Y3F1QkNxa0g5TTdMNmNuVk9Nc1VwbGFYS2MyREMtVmp3?oc=5","date":"2025-04-15","type":"pipeline","source":"GlobeNewswire","summary":"Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets - GlobeNewswire","headline":"Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) f","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNMlA2ZlNhaG5jWlZPblNsVU5JcEhwb2F6Y19mZjZObXhtTGlIekw0NDI5VE9tcHhlXzZDdHVUU2pSQUpSLVZrRmxKUlY2MzJSYUhsZHVNb0JMbHhCOWNyZjM5NHRxOWpnanV1MDJoS19vM3NuN0pmOTB3ZW9UbE5ZLTNUTkd2Wjd1WXZRb2NyZGIwTkdk?oc=5","date":"2023-12-21","type":"pipeline","source":"Yahoo Finance","summary":"Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth - Yahoo Finance","headline":"Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPZlpJLUswNHBQelpvSHd0S0NodUl5X0tLRGViWWNGVlgwcDFwQVdtWXRKTkw5eEV6TFF0NmVhQ2V3a2wtSmhOd0FrZjFEdlNOYXhyekpaMTM5TDNNR3RsQ3BnSGh5anF2N2lnVlNGbVJlbDhrTzFxZm5wLTFXS1d5bjlwN1NXWVJRU25neg?oc=5","date":"2023-12-14","type":"pipeline","source":"Mesothelioma Center","summary":"Polaris Submits Application for New Mesothelioma Treatment - Mesothelioma Center","headline":"Polaris Submits Application for New Mesothelioma Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFB5ZkEyMU1tanczbnNRTm40NTZLVFpmVXFleFYtRGpkSk0zV1NBZXBEUnY1aXpZNVNMQUlaUUdiWlF2S3Y4Q1hnbDh6VkVaR3FUSmVWRGZiTVJZUGVhTGc5ai1NVTVGZmxqTE1reTRjaXpLXzNHSTlROTJ1bDV6QQ?oc=5","date":"2023-08-16","type":"trial","source":"Clinical Trials Arena","summary":"GCAR, Polaris initiate trial of glioblastoma therapy - Clinical Trials Arena","headline":"GCAR, Polaris initiate trial of glioblastoma therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPLTdDMXk4R0FZZmllNjNnUHJzYWpfMHhKazlWWTJGVTZkYXVaMEduZDkybW5LTk5oSjZHVHNKVjZrSHNBSWFxX0RnV0pTWkEwcUF1bURGV0w4ckVhSWRhOTVuLXNjc0N3cVB3YWVuZVNJN2xSS1lVV25rcTViQW4tUWZRRnNHUHlxNHN0eUtjSEhiY0hyMHQxMjcxMlAxY3liTEZOZ3Z4RFZFVXV0UkhNQmROa3N1QjV5b2EtVTNwR0dqUkxGR0J1aWs2M29NYjhUcFRtM3phVnRlNElvbjI4S0QyMFVUUFA0OERmM29pcmFwOXh5cGl4NGFOX3g?oc=5","date":"2023-08-15","type":"trial","source":"Business Wire","summary":"Global Coalition for Adaptive Research and Polaris Group Announce Commencement of ADI-PEG 20 in GBM AGILE Trial - Business Wire","headline":"Global Coalition for Adaptive Research and Polaris Group Announce Commencement of ADI-PEG 20 in GBM AGILE Trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}